Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial

NCT03990636 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Actinic Cheilitis
Leukoplakia
Erythroplakia

Interventions

DRUG: Metil 5-aminolevulinate

Sponsor

Instituto Nacional de Cancer, Brazil